Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy

Methodist Health System

Status: Completed

Conditions: Chronic Hepatic; Liver Diseases

Treatments: Procedure: EUS-guided liver biopsy at MDMC

Study type: Observational

Funder types: Other

Identifiers

NCT04055870

045.GID.2017.D

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).

Full description

The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC). This is a clinical quality improvement (CQI) initiative to evaluate outcomes within our institution. The data collected will be used to inform new innovative ways to improve EUS-guided liver biopsy with an ultimate goal of improving the quality of patient care. The clinical outcomes of this patient population have not been previously systematically reviewed in MDMC. Currently, the procedure in not being performed routinely at Methodist Dallas Medical Center (MDMC). However, with new technical and physician expertise, this option is now available at our institution. PI will evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients requiring histologic examination of their liver at MDMC.

Enrollment: 24 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• Undergone EUS-guided liver biopsy at MDMC

Exclusion criteria

• Below 18 years of age
• Did not undergo EUS-guided liver biopsy at MDMC

Trial design

24 participants in 1 patient group

Undergone EUS-guided liver biopsy at MDMC

Description:

Undergone EUS-guided liver biopsy at MDMC

Treatment:

Procedure: EUS-guided liver biopsy at MDMC